|
| Status |
Public on Mar 16, 2011 |
| Title |
DLBCL patient_A0020373 |
| Sample type |
RNA |
| |
|
| Source name |
DLBCL
|
| Organism |
Homo sapiens |
| Characteristics |
pfs.status: 1
pfs.time: 169
response: PD
spdpct: -11.11
classspd10: 1
sgn40dx: 1
|
| Treatment protocol |
Patients were all treated with SGN-40
|
| Extracted molecule |
total RNA |
| Extraction protocol |
total cellular RNA were extracted with mirVanaTM miRNA Isolation Kit (Ambion, Austin, TX)
|
| Label |
biotin
|
| Label protocol |
according to the manufacturer’s instruction
|
| |
|
| Hybridization protocol |
according to the manufacturer’s instruction
|
| Scan protocol |
according to the manufacturer’s instruction
|
| Description |
A0020373
|
| Data processing |
Expression was normalized and estimated using VSN.
|
| |
|
| Submission date |
Oct 02, 2009 |
| Last update date |
Mar 16, 2011 |
| Contact name |
Peng Yue |
| E-mail(s) |
[email protected]
|
| Phone |
650-467-3587
|
| Organization name |
Genentech Inc
|
| Street address |
1 DNA Way
|
| City |
South San Francisco |
| State/province |
CA |
| ZIP/Postal code |
94080 |
| Country |
USA |
| |
|
| Platform ID |
GPL6244 |
| Series (1) |
| GSE18376 |
Gene expression profiling of human DLBCL tumor samples (SGN-40 trial) |
|
